article June 10, 2021

FDA leader: ‘stockpiling’ could transform clinical trial system

In the fourth and final article of this Outsourcing Pharma series, Acting FDA Commissioner Janet Woodcock discusses ways to overcome barriers in the clinical research industry, including the integration of research into large health systems to connect clinical research to clinical care. As Javara CEO Jennifer Byrne shared in an earlier article, an integrated approach is critical to building stronger relationships between researchers, doctors, and patients, and Janet Woodcock only furthers this by adding insights on how the different roles across the industry can work together for success. Click the link below to view the full article:

View Article